Business context and reporting period
Sumitomo Mitsui Financial Group, Inc. (SMFG) is a Japan-based financial holding company with commercial banking, securities, leasing, payment and consumer-finance operations. This Form 20-F is an audited annual report for the fiscal year ended March 31, 2021, prepared under IFRS and reported in Japanese yen. Although the request refers to “2020 Q4,” the filing provides annual results, not a standalone quarter; Q4-specific financial results are not clearly provided in the supplied text.
Key financial metrics
| Metric | FY ended March 31, 2021 | Prior comparable period | Change |
|---|---|---|---|
| Total operating income | ¥3,165.6bn | ¥2,703.9bn | Up 17% |
| Net interest income | ¥1,383.1bn | ¥1,316.3bn | Up 5% |
| Net fee and commission income | ¥972.7bn | ¥943.3bn | Up 3% |
| Impairment charges on financial assets | ¥282.5bn | ¥259.9bn | Up ¥22.5bn |
| Operating expenses | ¥1,963.0bn | ¥2,185.2bn | Down 10% |
| Profit before tax | ¥956.5bn | ¥282.8bn | Increased |
| Net profit | ¥705.1bn | ¥231.0bn | Increased |
| Profit attributable to SMFG shareholders | ¥687.5bn | ¥200.1bn | Increased |
| Basic earnings per share | ¥501.73 | ¥145.48 | Increased |
| Cash flow from operating activities | ¥18,322.4bn | ¥8,883.2bn | Higher |
| Cash flow from investing activities | (¥7,780.9bn) | (¥2,992.7bn) | Larger outflow |
| Cash flow from financing activities | (¥684.4bn) | (¥1,131.6bn) | Smaller outflow |
| Cash and cash equivalents at year-end | ¥71,548.7bn | ¥61,203.5bn | Up ¥10,345.2bn |
At March 31, 2021, total assets were ¥235,025.0bn, loans and advances ¥97,714.9bn, deposits ¥155,493.7bn, total liabilities ¥222,748.8bn and total equity ¥12,276.2bn. Deposits exceeded loans by ¥57,778.7bn; the reported loan-to-deposit ratio was 63%. The company’s consolidated LCR was 140.1% for the three months ended March 31, 2021.
Regulatory capital ratios at year-end, calculated under Japanese GAAP, were 18.61% total capital, 16.96% Tier 1 and 16.00% Common Equity Tier 1 for SMFG consolidated. The leverage ratio was 5.65%. These exceeded the applicable minimums disclosed in the filing.
Gross impaired loans and advances rose to ¥1,171.6bn from ¥845.3bn; the gross impaired-loan ratio increased to 1.2% from 0.9%. The allowance for loan losses increased to ¥849.3bn from ¥706.4bn. Net impaired loans were ¥748.4bn.
Material changes versus the prior year
- Income growth was driven mainly by a ¥302.0bn swing in financial assets and liabilities at fair value through profit or loss, from a ¥21.9bn loss to ¥280.0bn income, and a ¥103.7bn increase in net trading income. Management attributed much of the fair-value improvement to equity index-linked investment trusts and trading gains on foreign exchange transactions.
- Interest income fell 26%, primarily because lower average rates reduced loan income. Interest expense fell 64%, largely reflecting lower foreign deposit funding costs. The net effect was a 5% increase in net interest income.
- Credit impairment charges increased 9% as COVID-affected corporate borrowers drove higher loan-loss provisions. Gross impaired loans and restructured loans also increased.
- Deposits increased 12%, while loans and advances increased 3%. The filing attributes deposit growth partly to customers maintaining liquidity, government cash payments and reduced consumption.
- Investment securities rose 42% to ¥31,051.5bn, principally from increased holdings of Japanese government bonds and U.S. government securities. Net unrealized gains on domestic equity instruments increased to ¥2,527.0bn.
- Profit benefited from lower other expenses and a ¥42.4bn goodwill impairment charge was recognized, compared with none in FY2020. Income tax expense rose to ¥251.4bn from ¥51.8bn, partly due to deferred tax effects.
Outlook, management commentary and risks
- Outlook and strategy: The medium-term management plan runs through March 2023 and emphasizes transforming existing businesses, pursuing growth in asset-light services, payments and Asia, and improving management quality and efficiency. The filing gives no numerical FY2022 earnings guidance. For credit-loss modelling, management’s base case assumes Japanese GDP growth of 3.3% in FY2022 and 2.0% in FY2023, and global GDP growth of 5.6% and 3.9%, respectively; these are assumptions, not earnings guidance.
- COVID-19: Management describes the pandemic’s duration, new variants, vaccine effectiveness and economic effects as uncertain. Further customer deterioration could increase impaired loans, credit costs and securities losses, while additional lending could increase risk-weighted assets.
- U.S. regulatory matter: SMBC and its New York branch remain subject to a 2019 Federal Reserve written agreement to address anti-money-laundering and sanctions compliance deficiencies. The group reports restrictions on certain new U.S. financial activities and acquisitions while remediation is pending; failure to remediate could require divestiture or termination of some U.S. activities.
- Other material risks: Low interest rates and competition may pressure bank spreads; market-price changes can affect securities values, earnings and capital; credit-rating downgrades could raise funding costs or constrain access to liquidity; and the transition from LIBOR creates operational, valuation and hedge-accounting risks. Cybersecurity, operational disruption, litigation, sanctions and climate-related credit and physical risks are also identified.
- Contingencies: Nominal loan commitments were ¥71,677.8bn and financial guarantees and other credit-related contingent liabilities were ¥9,872.7bn at year-end. These amounts are not expected cash outflows in full; many commitments may expire undrawn. Routine litigation was not expected to have a significant adverse effect, though outcomes cannot be assured.
- Shareholder returns and controls: Management states a progressive dividend policy and seeks a 40% payout ratio under Japanese GAAP by the end of the current plan. FY2021 dividends were reported as ¥195 per share; the proposed ¥95 per share year-end dividend remained subject to shareholder approval. Management and the auditor reported effective internal control over financial reporting, with an unqualified audit opinion.
Important facts for investors to verify
- Confirm the period: this is FY2021 annual reporting, not a standalone 2020 Q4 filing.
- Assess how much of the earnings rebound came from volatile fair-value and trading gains, and whether those gains are repeatable.
- Review COVID-related credit assumptions, sector-specific additional ECL adjustments, impaired loans and the increase in restructured lending.
- Track progress and regulatory status of SMBC’s U.S. AML and sanctions remediation, including any changes to U.S. business restrictions.
- Verify capital and liquidity ratios on the applicable regulatory basis, and monitor the effect of securities valuations and future Basel requirements.
- Review the composition and valuation sensitivity of the expanded securities portfolio, including equity holdings and unrealized gains.
- Check dividend approval and the Japanese-GAAP payout ratio, rather than treating the stated FY2021 dividend as a forward commitment.